Terms: = Thyroid cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M AND Prognosis
4 results:
1. Isocitrate dehydrogenase 2 regulates the proliferation of triple-negative breast cancer through the ferroptosis pathway.
Zhang C; Zhou Y; Chen T; Bhushan S; Sun S; Zhang P; Yang Y
Sci Rep; 2024 Feb; 14(1):4732. PubMed ID: 38413708
[TBL] [Abstract] [Full Text] [Related]
2. LINC00571 drives tricarboxylic acid cycle metabolism in triple-negative breast cancer through HNRNPK/ILF2/idh2 axis.
Xi Z; Huang H; Hu J; Yu Y; Ma X; Xu M; Ming J; Li L; Zhang H; Chen H; Huang T
J Exp Clin Cancer Res; 2024 Jan; 43(1):22. PubMed ID: 38238853
[TBL] [Abstract] [Full Text] [Related]
3. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
4. Tall Cell Carcinoma with Reverse Polarity of Breast: Report of a Case with Unique Morphologic and Molecular Features.
Jassim M; Premalata CS; Okaly G; Srinivas C
Turk Patoloji Derg; 2021; 37(2):183-188. PubMed ID: 33021737
[TBL] [Abstract] [Full Text] [Related]
